日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Oncorhynchus keta NADH-ubiquinone oxidoreductase chain 3 (MT-ND3), partial CSB-YP654975OBG1
CSB-EP654975OBG1
CSB-BP654975OBG1
CSB-MP654975OBG1
CSB-EP654975OBG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phascolosorex dorsalis Cytochrome b (MT-CYB), partial CSB-YP654976PGX
CSB-EP654976PGX
CSB-BP654976PGX
CSB-MP654976PGX
CSB-EP654976PGX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phoca largha Cytochrome b (MT-CYB), partial CSB-YP654977PCAP
CSB-EP654977PCAP
CSB-BP654977PCAP
CSB-MP654977PCAP
CSB-EP654977PCAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Petromyzon marinus NADH-ubiquinone oxidoreductase chain 2 (MT-ND2), partial CSB-YP654978EUC
CSB-EP654978EUC
CSB-BP654978EUC
CSB-MP654978EUC
CSB-EP654978EUC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Petromyzon marinus NADH-ubiquinone oxidoreductase chain 4 (MT-ND4), partial CSB-YP654979EUC
CSB-EP654979EUC
CSB-BP654979EUC
CSB-MP654979EUC
CSB-EP654979EUC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo pygmaeus Cytochrome b (MT-CYB), partial CSB-YP654980EXP
CSB-EP654980EXP
CSB-BP654980EXP
CSB-MP654980EXP
CSB-EP654980EXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Puffinus tenuirostris Cytochrome b (MT-CYB), partial CSB-YP654981PCAQ
CSB-EP654981PCAQ
CSB-BP654981PCAQ
CSB-MP654981PCAQ
CSB-EP654981PCAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sminthopsis crassicaudata Cytochrome b (MT-CYB), partial CSB-YP654982SZT
CSB-EP654982SZT
CSB-BP654982SZT
CSB-MP654982SZT
CSB-EP654982SZT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Seleucidis melanoleucus Cytochrome b (MT-CYB), partial CSB-YP654983SCAU
CSB-EP654983SCAU
CSB-BP654983SCAU
CSB-MP654983SCAU
CSB-EP654983SCAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmo salar Cytochrome b (mt-cyb), partial CSB-YP654984SWI
CSB-EP654984SWI
CSB-BP654984SWI
CSB-MP654984SWI
CSB-EP654984SWI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thylacinus cynocephalus Cytochrome b (MT-CYB), partial CSB-YP654985TEL
CSB-EP654985TEL
CSB-BP654985TEL
CSB-MP654985TEL
CSB-EP654985TEL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytochrome c oxidase subunit 3 (MT-CO3), partial CSB-YP654986TCK1
CSB-EP654986TCK1
CSB-BP654986TCK1
CSB-MP654986TCK1
CSB-EP654986TCK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ursus thibetanus Cytochrome b (MT-CYB), partial CSB-YP654987UAY
CSB-EP654987UAY
CSB-BP654987UAY
CSB-MP654987UAY
CSB-EP654987UAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mormopterus kalinowskii Cytochrome b (MT-CYB), partial CSB-YP654988MBAX1
CSB-EP654988MBAX1
CSB-BP654988MBAX1
CSB-MP654988MBAX1
CSB-EP654988MBAX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Erinaceus europaeus Cytochrome b (MT-CYB), partial CSB-YP654989EMQ
CSB-EP654989EMQ
CSB-BP654989EMQ
CSB-MP654989EMQ
CSB-EP654989EMQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Locusta migratoria Cytochrome b (MT-CYB), partial CSB-YP654990LHY
CSB-EP654990LHY
CSB-BP654990LHY
CSB-MP654990LHY
CSB-EP654990LHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ornithorhynchus anatinus Cytochrome c oxidase subunit 3 (MT-CO3), partial CSB-YP654991OEX1
CSB-EP654991OEX1
CSB-BP654991OEX1
CSB-MP654991OEX1
CSB-EP654991OEX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Platymonas subcordiformis NADH-ubiquinone oxidoreductase chain 3 (ND3), partial CSB-YP654992PMW1
CSB-EP654992PMW1
CSB-BP654992PMW1
CSB-MP654992PMW1
CSB-EP654992PMW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nycticeius humeralis Cytochrome b (MT-CYB), partial CSB-YP654993NAAX1
CSB-EP654993NAAX1
CSB-BP654993NAAX1
CSB-MP654993NAAX1
CSB-EP654993NAAX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Promops centralis Cytochrome b (MT-CYB), partial CSB-YP654994PCAR1
CSB-EP654994PCAR1
CSB-BP654994PCAR1
CSB-MP654994PCAR1
CSB-EP654994PCAR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×